Aptorum Group Limited (NASDAQ:APM) Short Interest Up 70.4% in October

Aptorum Group Limited (NASDAQ:APM) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 4,600 shares, an increase of 70.4% from the October 15th total of 2,700 shares. Based on an average trading volume of 19,700 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.2% of the company’s stock are sold short.

Aptorum Group Stock Performance

Shares of Aptorum Group stock opened at $1.20 on Thursday. The company has a 50-day simple moving average of $1.93 and a two-hundred day simple moving average of $3.31. Aptorum Group has a one year low of $1.20 and a one year high of $17.49.

Hedge Funds Weigh In On Aptorum Group

A hedge fund recently bought a new stake in Aptorum Group stock. Murchinson Ltd. acquired a new stake in shares of Aptorum Group Limited (NASDAQ:APM) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,000 shares of the company’s stock, valued at approximately $133,000. Murchinson Ltd. owned approximately 0.27% of Aptorum Group as of its most recent SEC filing. Institutional investors and hedge funds own 3.80% of the company’s stock.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.